Asston Pharmaceuticals Ltd
Incorporated in 2019, Asston Pharmaceuticals Ltd is in the business of manufacturing pharmaceutical products.[1]
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE %
- ROE %
- Face Value ₹
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Quarterly Results
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Dividend Payout % |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Figures in Rs. Crores
| Equity Capital |
| Reserves |
| Total Liabilities |
| CWIP |
| Investments |
| Total Assets |
Cash Flows
Figures in Rs. Crores
| Net Cash Flow |
| Free Cash Flow |
| CFO/OP |
Ratios
| Debtor Days |
| Inventory Days |
| Days Payable |
| Cash Conversion Cycle |
| Working Capital Days |
| ROCE % |
Insights
In beta| Mar 2023 | Mar 2024 | May 2025 | |
|---|---|---|---|
| Export Revenue (% of Total Sales) % ・Standalone data |
|
||
| Pharmaceuticals Sales (% of Total Sales) % ・Standalone data |
|||
| Sierra Leone Revenue (% of Total Sales) % ・Standalone data |
|||
| Top 5 Customer Concentration (% of Revenue) % ・Standalone data |
|||
| Total Production Volume MT ・Standalone data |
|||
| Number of Registered Product Brands count ・Standalone data |
|||
| Order Book USD ・Standalone data |
|||
Extracted by Screener AI
Documents
Announcements
-
Shareholder Meeting / Postal Ballot-Outcome of AGM
- Asston Pharmaceuticals held its 7th AGM on 29 September 2026; resolutions included financial adoption and director remuneration increases.
-
Closure of Trading Window
- Trading window closed from 1 October 2026 until 48 hours after half-year results.
-
Reg. 34 (1) Annual Report.
- Asston Pharmaceuticals submitted FY2025-26 annual report; notes IPO, July 2025 listing, and new plant production start.
-
Notice Of 7Th Annual General Meeting
- 7th AGM on 29 Sep 2026; approve FY26 accounts, auditors, and director remuneration increases.
-
Announcement under Regulation 30 (LODR)-Allotment
- Board approved preferential allotment of 24,10,431 shares at Rs.115 to 15 investors on 05 Sep 2026.
Business Overview:[1]
APL offers pharmaceutical products in the form of Tablet, Capsules, Syrup, Sachet and Injection (LVP and SVP). The company has WHO GMP approved manufacturing units for manufacturing
the entire products range and also has
a tie up with a NABL Accredited Laboratory.